Abstract
While androgen deprivation therapy (ADT) decreases the risk of prostate cancer specific mortality in men with high risk localized prostate cancer treated with radiotherapy, it worsens cardiovascular (CV) risk factor profiles. Patients with pre-existing traditional cardiac risk factors who are treated with ADT have a higher rate of CV mortality than patients without risk factors.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
